Undermining the foundations of bacterial resistance

Scientists from the University of Guelph have used the Canadian Light Source (CLS) at the University of Saskatchewan to better understand how several infectious bacteria, including E. coli., build a protective sugar-based barrier that helps cloak their cells.

Creating an arsenal of COVID-19 therapeutics

Using the CLS, McGill researchers have discovered a small molecule that may help combat COVID-19 and could contribute to a new arsenal of treatments slowly making their way to market.

Analyzing antibodies

Researchers from the University of Toronto have developed antibodies that can neutralize COVID-19.


Cradle-to-grave product development of successful detergent for athletic use.

Biotron Laboratories Inc.

Determination of the chemical differences between inorganic salt-based nutritional supplements and amino acid chelate products.

The future of stroke treatment

A team of international collaborators has been researching a promising new therapeutic for the treatment of strokes and other brain injuries.

Fighting antibiotic resistance

Researchers report new insights into how a class of antibiotics commonly used in both medicine and agriculture are rendered useless by resistant germs.

Battling bad bugs

University of Guelph scientists fight antibiotic resistance by using our synchrotron to study scab disease in potatoes.

Cleaning pathogens from the air

University of Saskatchewan scientists have designed an air sanitizing device that could help protect us from airborne pathogens like the ones that cause COVID-19 and the common flu.

CO2 and increased immunity | Video

Dr. Dustin King with Simon Fraser University and colleagues are using our CMCF beamlines to get a better understanding of how CO2 could be controlled to improve our immunity.

Helping stroke patients | Video

Dr. Jake Pushie's team at the University of Saskatchewan is examining risk factors for bleeding in the brain after stroke.

In search of the perfect system

Streptavidin and biotin form a strong bond invaluable for many biotechnological applications. Researchers have taken a new approach to improve these widely used biotechnology tools.

Innovative testing

Researchers from the CLS and Université Laval are trying to create a device that would make healthcare testing more efficient

Finding new therapies

Dr. Jiang Yin is using the CLS to find new therapies that will help treat COVID-19.

How cellular proteins control cancer spread

A new insight into cell signals that control cancer growth and migration could help in the search for effective anti-cancer drugs, according to McGill University researchers who used the CLS.

Diabetes discovery challenges known research

A discovery by an international group of scientists challenges known research on diabetes and may open the door to new therapeutic approaches for the disease that affects nearly 500 million people globally.

Targeting a deadly childhood winter illness

CLS helps biopharmaceutical company Merck to make a vaccine breakthrough for Respiratory Syncytial Virus (RSV), a virus that is one of the leading causes of hospitalization in babies.

New understanding of antibiotic synthesis

Researchers have made great strides in understanding the functioning of enzymes that play and integral role in the production of antibiotics and other therapeutics.

Analyzing poppies to make better drugs

A team of researchers from the University of Calgary has uncovered new information about a class of plant enzymes that could have implications for the pharmaceutical industry.

A new generation of anti-malarial drugs

An international research team used the CLS to help determine the atomic structure of a protein kinase in parasites that cause malaria, which could help create a new generation of anti-malarial drugs.

The future of fighting infections

Researchers used the CLS to study proteins that a pathogen uses to break down sugar chains (glycans) present in human tissue during infections. This could lead to new treatments approaches for the bacterium.

Preventing heart attacks

Scientists from Quebec take an important step towards finding a potential cure for the disease that causes some strokes and heart attacks.

Fighting antibiotic resistance

Researchers from the Universities of Guelph and Alberta used the CLS to identify a possible target in the prevention and treatment of bacterial infections.

Helping people to hear

Using advanced techniques at the CLS, scientists have created three-dimensional images of the complex interior anatomy of the human ear, which is key to improving the design of hearing implants.

Helping to shrink cancer tumours

Guided by “blueprints” produced at the CLS, scientists made structural changes to an antibody that is now showing a lot of potential for reducing cancer tumours.

Stress can lead to heart failure

Scientists have shown that heart arrhythmia can be acquired by people who are stressed out even if they have no genetic predisposition. This condition serves as a warning signal for atrial fibrillation and potential heart failure. The good news is that these researchers may have also discovered a potential therapy.